| AMP |
Report |
Adj. Operating EPS (Q2 2026) |
BEAT |
pred ~$11.10 vs. cons $10.75 |
MEDIUM |
| AMP |
Report |
Wrap Net Flows - AWM (Q2 2026) |
MISS |
pred ~$5.5B vs. cons $5.86B |
MEDIUM |
| AMP |
Report |
Annualized Organic Growth (Q2 2026) |
MISS |
pred ~1.1% vs. cons 1.29% |
MEDIUM |
| AMP |
Guide |
AWM Margin (FY 2026) |
UNKNOWN |
guide ~29-30% vs. cons UNKNOWN |
LOW |
| AMP |
Guide |
G&A Growth (FY 2026) |
UNCHANGED |
guide mid-single digit vs. cons $3.89B |
MEDIUM |
| AMP |
Guide |
Capital Return (FY 2026) |
UNCHANGED |
guide 85-90% vs. cons UNVERIFIED |
HIGH |
| AMP |
Guide |
Organic Growth Target (FY 2026) |
UNCHANGED |
guide 4-5% reaffirmed vs. cons 3.83% |
HIGH |
| AMP |
Guide |
Comerica/Huntington Timeline (Q3/Q4 2026) |
UNCHANGED |
Comerica fully out Q3-end; Huntington Q4 on track vs. prior guidance |
HIGH |
| AMP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| AMP |
Return |
5-day cumulative residual |
-3.5% (FADE) |
FADE - implicit flow cut pulls estimates lower; no new catalyst to sustain the pre-run |
MEDIUM |